← Open Payments lookup

ANYINKE ATABONG: Open Payments

NPI 1316359771 · ROCKVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,116 in 89 payments from 21 companies in 2025. Trend: 2023 $2,945 · 2024 $4,749 · 2025 $4,116

Food & beverage: $2,636Consulting: $1,480
CompanyPaymentsAmount
Otsuka Pharmaceutical Development & Commercialization, Inc.3$1,480
ABBVIE INC.15$402
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$279
Otsuka America Pharmaceutical, Inc.9$268
Neurocrine BioSciences, Inc.4$267
Alkermes, Inc.6$259
Supernus Pharmaceuticals, Inc.6$208
E.R. Squibb & Sons, L.L.C.3$159
Lundbeck LLC8$158
Lilly USA, LLC6$119

Products named: VRAYLAR, CAPLYTA, INGREZZA, Qelbree, ABILIFY MAINTENA, REXULTI, COBENFY, ARISTADA.

Industry payments across MD — which companies pay providers there.